Co-Authors
This is a "connection" page, showing publications co-authored by Tom Luedde and Timo Brandenburger.
Connection Strength
0.298
-
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021 Sep; 8:100164.
Score: 0.239
-
Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literature. Clin Case Rep. 2021 May; 9(5):e04068.
Score: 0.059